-
Fund Dashboard
- Holdings
Select Biotechnology Portfolio
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 544.16 mm | 2.97 mm shares | 11.45 | Common equity | Long | USA |
AMGN Amgen Inc. | 419.71 mm | 1.48 mm shares | 8.83 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 370.70 mm | 1.88 mm shares | 7.80 | Common equity | Long | USA |
Fidelity Securities Lending Cash Central Fund | 295.79 mm | 295.76 mm shares | 6.23 | Short-term investment vehicle | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 221.52 mm | 473.21 k shares | 4.66 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 164.97 mm | 651.87 k shares | 3.47 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 154.68 mm | 206.18 k shares | 3.26 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 153.37 mm | 1.66 mm shares | 3.23 | Common equity | Long | USA |
ARGENX SE SPONSORED ADR
|
106.05 mm | 172.00 k shares | 2.23 | Common equity | Long | Netherlands |
UCB SA
|
104.39 mm | 532.97 k shares | 2.20 | Common equity | Long | Belgium |
ACLX Arcellx, Inc. | 91.94 mm | 1.04 mm shares | 1.94 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 89.73 mm | 659.41 k shares | 1.89 | Common equity | Long | Denmark |
PCVX Vaxcyte, Inc. | 84.47 mm | 895.38 k shares | 1.78 | Common equity | Long | USA |
ZEALAND PHARMA A/S
|
77.81 mm | 752.23 k shares | 1.64 | Common equity | Long | Denmark |
BIOHAVEN LTD
|
76.60 mm | 1.66 mm shares | 1.61 | Common equity | Long | Virgin Islands (British) |
INSM Insmed Incorporated | 75.15 mm | 999.82 k shares | 1.58 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 65.14 mm | 1.63 mm shares | 1.37 | Common equity | Long | USA |
ARRIVENT BIOPHARMA INC
|
58.95 mm | 1.97 mm shares | 1.24 | Common equity | Long | USA |
NTRA Natera, Inc. | 58.64 mm | 349.53 k shares | 1.23 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 58.50 mm | 157.89 k shares | 1.23 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 56.13 mm | 3.04 mm shares | 1.18 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 55.18 mm | 964.65 k shares | 1.16 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 53.31 mm | 2.98 mm shares | 1.12 | Common equity | Long | UK |
IRON Disc Medicine, Inc. | 49.19 mm | 775.29 k shares | 1.04 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 47.55 mm | 493.35 k shares | 1.00 | Common equity | Long | USA |
MERUS B.V.
|
44.66 mm | 996.05 k shares | 0.94 | Common equity | Long | Netherlands |
MDGL Madrigal Pharmaceuticals, Inc. | 44.40 mm | 135.29 k shares | 0.93 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 43.14 mm | 747.18 k shares | 0.91 | Common equity | Long | USA |
BIO AB2 HOLDINGS LLC ARC
|
37.14 mm | 1.95 mm shares | 0.78 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 34.67 mm | 805.72 k shares | 0.73 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 33.85 mm | 585.10 k shares | 0.71 | Common equity | Long | USA |
MRNA Moderna, Inc. | 33.10 mm | 768.62 k shares | 0.70 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 32.98 mm | 947.72 k shares | 0.69 | Common equity | Long | USA |
MNKD MannKind Corporation | 29.88 mm | 4.41 mm shares | 0.63 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 29.01 mm | 1.88 mm shares | 0.61 | Common equity | Long | USA |
ROIVANT SCIENCES LTD
|
28.27 mm | 2.22 mm shares | 0.59 | Common equity | Long | Bermuda |
VERA Vera Therapeutics, Inc. | 28.22 mm | 567.33 k shares | 0.59 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 27.81 mm | 510.86 k shares | 0.59 | Common equity | Long | Cayman Islands |
RARE Ultragenyx Pharmaceutical Inc. | 27.52 mm | 577.73 k shares | 0.58 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 26.00 mm | 268.90 k shares | 0.55 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 25.25 mm | 1.14 mm shares | 0.53 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 24.13 mm | 788.47 k shares | 0.51 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 24.13 mm | 418.35 k shares | 0.51 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 23.59 mm | 445.56 k shares | 0.50 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 23.00 mm | 539.63 k shares | 0.48 | Common equity | Long | Canada |
VRDN Viridian Therapeutics, Inc. | 22.71 mm | 1.05 mm shares | 0.48 | Common equity | Long | USA |
BNTX BioNTech SE | 20.78 mm | 175.50 k shares | 0.44 | Common equity | Long | Germany |
NATIONAL RESILIENCE INC SER B PC PP | 20.24 mm | 732.06 k shares | 0.43 | Preferred equity | Long | USA |
BRIDGEBIO PHARMA INC PIPE
|
19.87 mm | 733.41 k shares | 0.42 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 19.63 mm | 717.56 k shares | 0.41 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 18.77 mm | 665.62 k shares | 0.40 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 18.57 mm | 423.91 k shares | 0.39 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 18.56 mm | 231.51 k shares | 0.39 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 18.05 mm | 5.57 mm shares | 0.38 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 17.70 mm | 392.13 k shares | 0.37 | Common equity | Long | USA |
GERN Geron Corporation | 17.63 mm | 4.28 mm shares | 0.37 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 16.91 mm | 676.56 k shares | 0.36 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 16.56 mm | 366.40 k shares | 0.35 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 15.81 mm | 442.38 k shares | 0.33 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 15.71 mm | 1.08 mm shares | 0.33 | Common equity | Long | USA |
VRNA Verona Pharma plc | 15.65 mm | 394.99 k shares | 0.33 | Common equity | Long | UK |
PTCT PTC Therapeutics, Inc. | 15.49 mm | 352.91 k shares | 0.33 | Common equity | Long | USA |
RNAC Cartesian Therapeutics, Inc. | 15.35 mm | 815.35 k shares | 0.32 | Common equity | Long | USA |
ORUKA THERAPEUTICS INC PIPE
|
15.32 mm | 704.88 k shares | 0.32 | Common equity | Long | USA |
SENSORION SA
|
14.83 mm | 20.28 mm shares | 0.31 | Common equity | Long | France |
NTLA Intellia Therapeutics, Inc. | 13.74 mm | 879.92 k shares | 0.29 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 13.73 mm | 985.73 k shares | 0.29 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 13.64 mm | 4.70 mm shares | 0.29 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 13.58 mm | 261.85 k shares | 0.29 | Common equity | Long | USA |
PROTHENA CORP PLC
|
11.96 mm | 738.12 k shares | 0.25 | Common equity | Long | Ireland |
ELVN Enliven Therapeutics, Inc. | 11.68 mm | 479.04 k shares | 0.25 | Common equity | Long | USA |
TECTONIC THERAPEUTIC INC PIPE
|
10.73 mm | 215.51 k shares | 0.23 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 10.72 mm | 1.21 mm shares | 0.23 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 10.71 mm | 1.13 mm shares | 0.23 | Common equity | Long | USA |
CRISPR THERAPEUTICS AG
|
10.34 mm | 202.01 k shares | 0.22 | Common equity | Long | Switzerland |
BIO AB2 HOLDINGS LLC ADI
|
10.26 mm | 1.95 mm shares | 0.22 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 10.14 mm | 278.05 k shares | 0.21 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 9.97 mm | 367.90 k shares | 0.21 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 9.95 mm | 293.26 k shares | 0.21 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 9.75 mm | 231.81 k shares | 0.21 | Common equity | Long | Cayman Islands |
UPB Upstream Bio, Inc. | 9.64 mm | 440.96 k shares | 0.20 | Common equity | Long | USA |
GALDERMA GROUP AG
|
9.39 mm | 91.67 k shares | 0.20 | Common equity | Long | Switzerland |
ALEC Alector, Inc. | 9.16 mm | 3.54 mm shares | 0.19 | Common equity | Long | USA |
ATYR aTyr Pharma, Inc. | 8.91 mm | 2.52 mm shares | 0.19 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 8.79 mm | 211.91 k shares | 0.19 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 8.59 mm | 259.18 k shares | 0.18 | Common equity | Long | Cayman Islands |
METSERA INC SER B PC PP | 8.50 mm | 1.69 mm shares | 0.18 | Preferred equity | Long | USA |
TWST Twist Bioscience Corporation | 8.19 mm | 166.53 k shares | 0.17 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 8.14 mm | 1.08 mm shares | 0.17 | Common equity | Long | USA |
SUMMIT THERAPEUTICS INC PIPE
|
8.13 mm | 440.53 k shares | 0.17 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 8.10 mm | 284.85 k shares | 0.17 | Common equity | Long | USA |
SDGR Schrödinger, Inc. | 7.92 mm | 350.70 k shares | 0.17 | Common equity | Long | USA |
SCORPION THERAPEUTICS INC SER B PC PP | 7.50 mm | 3.10 mm shares | 0.16 | Preferred equity | Long | USA |
TRIVENI BIO INC SERIES B PC PP | 7.45 mm | 7.17 mm shares | 0.16 | Preferred equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 7.32 mm | 399.33 k shares | 0.15 | Common equity | Long | USA |
QTTB Q32 Bio Inc. | 6.99 mm | 259.90 k shares | 0.15 | Common equity | Long | USA |
Fidelity Cash Central Fund | 6.98 mm | 6.98 mm shares | 0.15 | Short-term investment vehicle | Long | USA |
AXSM Axsome Therapeutics, Inc. | 6.97 mm | 71.00 k shares | 0.15 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 6.68 mm | 474.72 k shares | 0.14 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 6.28 mm | 191.71 k shares | 0.13 | Common equity | Long | UK |
TNYA Tenaya Therapeutics, Inc. | 6.23 mm | 1.75 mm shares | 0.13 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 6.20 mm | 596.26 k shares | 0.13 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 6.15 mm | 309.17 k shares | 0.13 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 6.08 mm | 605.81 k shares | 0.13 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 5.85 mm | 2.36 mm shares | 0.12 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 5.76 mm | 221.12 k shares | 0.12 | Common equity | Long | USA |
TYRA Tyra Biosciences, Inc. | 5.69 mm | 363.10 k shares | 0.12 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 5.60 mm | 540.52 k shares | 0.12 | Common equity | Long | USA |
GOSS Gossamer Bio, Inc. | 5.53 mm | 7.91 mm shares | 0.12 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 5.52 mm | 51.70 k shares | 0.12 | Common equity | Long | Denmark |
WAVE LIFE SCIENCES LTD
|
5.28 mm | 349.81 k shares | 0.11 | Common equity | Long | Singapore |
INZY Inozyme Pharma, Inc. | 5.16 mm | 1.90 mm shares | 0.11 | Common equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 5.05 mm | 243.10 k shares | 0.11 | Common equity | Long | USA |
DSGN Design Therapeutics, Inc. | 5.03 mm | 839.13 k shares | 0.11 | Common equity | Long | USA |
CARDURION PHARMACEUTICALS INC SER B PC PP | 5.00 mm | 1.02 mm shares | 0.11 | Preferred equity | Long | USA |
SCORPION THERAPEUTICS INC SERIES C1 PC PP | 5.00 mm | 2.07 mm shares | 0.11 | Preferred equity | Long | USA |
FHTX Foghorn Therapeutics Inc. | 4.81 mm | 601.44 k shares | 0.10 | Common equity | Long | USA |
IMNM Immunome, Inc. | 4.77 mm | 352.28 k shares | 0.10 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 4.43 mm | 307.69 k shares | 0.09 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 4.34 mm | 782.81 k shares | 0.09 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 4.25 mm | 49.60 k shares | 0.09 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 3.99 mm | 145.46 k shares | 0.08 | Common equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 3.92 mm | 171.46 k shares | 0.08 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 3.88 mm | 213.40 k shares | 0.08 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 3.83 mm | 316.17 k shares | 0.08 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 3.72 mm | 1.12 mm shares | 0.08 | Common equity | Long | UK |
DNTH Dianthus Therapeutics, Inc. | 3.69 mm | 153.69 k shares | 0.08 | Common equity | Long | USA |
SEPN Septerna, Inc. | 3.55 mm | 140.20 k shares | 0.07 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 3.53 mm | 56.90 k shares | 0.07 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 3.51 mm | 352.92 k shares | 0.07 | Common equity | Long | USA |
CRESCENT BIOPHARMA INC PIPE
|
3.39 mm | 12.10 mm shares | 0.07 | Common equity | Long | USA |
GERN Geron Corporation | 3.19 mm | 2.10 mm shares | 0.07 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 3.17 mm | 127.17 k shares | 0.07 | Common equity | Long | USA |
CATX Perspective Therapeutics, Inc. | 3.10 mm | 713.70 k shares | 0.07 | Common equity | Long | USA |
ZBIO Zenas BioPharma, Inc. | 3.06 mm | 265.70 k shares | 0.06 | Common equity | Long | USA |
VTVT vTv Therapeutics Inc. | 2.85 mm | 178.20 k shares | 0.06 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 2.84 mm | 392.13 k shares | 0.06 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 2.81 mm | 59.94 k shares | 0.06 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 2.80 mm | 219.60 k shares | 0.06 | Common equity | Long | USA |
NGNE Neurogene Inc. | 2.54 mm | 99.86 k shares | 0.05 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 2.50 mm | 71.90 k shares | 0.05 | Common equity | Long | USA |
PHARVARIS BV
|
2.46 mm | 112.41 k shares | 0.05 | Common equity | Long | Netherlands |
SRPT Sarepta Therapeutics, Inc. | 2.36 mm | 17.69 k shares | 0.05 | Common equity | Long | USA |
RNAC Cartesian Therapeutics, Inc. | 2.32 mm | 5.39 mm shares | 0.05 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 2.28 mm | 667.10 k shares | 0.05 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 2.23 mm | 64.43 k shares | 0.05 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 2.01 mm | 61.02 k shares | 0.04 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 1.98 mm | 9.20 k shares | 0.04 | Common equity | Long | Cayman Islands |
JADE BIOSCIENCES INC PIPE
|
1.92 mm | 345.92 k shares | 0.04 | Common equity | Long | USA |
CANDID THERAPEUTICS INC SER B PC PP | 1.83 mm | 1.67 mm shares | 0.04 | Preferred equity | Long | USA |
ANNX Annexon, Inc. | 1.83 mm | 339.69 k shares | 0.04 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 1.79 mm | 112.40 k shares | 0.04 | Common equity | Long | USA |
KORRO BIO INC PIPE
|
1.71 mm | 32.87 k shares | 0.04 | Common equity | Long | USA |
UNIQURE N.V.
|
1.65 mm | 275.56 k shares | 0.03 | Common equity | Long | Netherlands |
CAMP4 Therapeutics Corporation | 1.26 mm | 262.89 k shares | 0.03 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 1.08 mm | 39.35 k shares | 0.02 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 1.06 mm | 149.90 k shares | 0.02 | Common equity | Long | USA |
RAPT RAPT Therapeutics, Inc. | 1.01 mm | 802.70 k shares | 0.02 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 968.01 k | 15.60 k shares | 0.02 | Common equity | Long | USA |
CTNM Contineum Therapeutics, Inc. Class A Common Stock | 876.71 k | 58.80 k shares | 0.02 | Common equity | Long | USA |
GKOS Glaukos Corporation | 818.81 k | 5.70 k shares | 0.02 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals, Inc. | 809.81 k | 1.01 mm shares | 0.02 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 760.26 k | 138.99 k shares | 0.02 | Common equity | Long | USA |
ELEVATEBIO LLC SER C PC PP | 628.14 k | 216.60 k shares | 0.01 | Preferred equity | Long | USA |
ASTRIA THERAPEUTICS INC WT
|
603.96 k | 115.14 k shares | 0.01 | Common equity | Long | USA |
SCHOLAR ROCK HOLDING CORP WT 12/31/2025 PP
|
586.80 k | 17.85 k shares | 0.01 | Common equity | Long | USA |
ADVM Adverum Biotechnologies, Inc. | 486.13 k | 73.21 k shares | 0.01 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 400.67 k | 15.00 k shares | 0.01 | Common equity | Long | USA |
SALIOGEN THERAPEUTICS INC SER B PC PP | 332.50 k | 94.46 k shares | 0.01 | Preferred equity | Long | USA |
IDORSIA LTD
|
282.63 k | 289.34 k shares | 0.01 | Common equity | Long | Switzerland |
AURA Aura Biosciences, Inc. | 270.67 k | 29.07 k shares | 0.01 | Common equity | Long | USA |
NOVOCURE LTD
|
222.70 k | 11.11 k shares | 0.00 | Common equity | Long | Jersey |
VTYX Ventyx Biosciences, Inc. | 218.69 k | 81.60 k shares | 0.00 | Common equity | Long | USA |
ABSI Absci Corporation | 121.70 k | 39.90 k shares | 0.00 | Common equity | Long | USA |
BOLD Boundless Bio, Inc. | 64.70 k | 23.70 k shares | 0.00 | Common equity | Long | USA |
CYCLERION THERAPEUTICS INC PP PIPE
|
10.43 k | 4.74 k shares | 0.00 | Common equity | Long | USA |
ORKA Oruka Therapeutics, Inc. | 2.17 k | 100.00 shares | 0.00 | Common equity | Long | USA |
OPTN OptiNose, Inc. | 1.24 k | 91.71 k shares | 0.00 | Common equity | Long | USA |
AFFERENT PHARMACEUTICALS INC SER C PC PP | 82.75 | 8.27 mm shares | 0.00 | Preferred equity | Long | USA |
AFFERENT PHARMACEUTICALS INC CONTINGENT VALUE RT 12/31/24
|
82.75 | 8.27 mm shares | 0.00 | Common equity | Long | USA |
DISC MEDICINE INC CVR RT
|
15.56 | 1.56 mm shares | 0.00 | Common equity | Long | USA |
GRITSTONE BIO INC WT
|
13.33 | 1.33 mm shares | 0.00 | Common equity | Long | USA |
CDAKQ Codiak BioSciences, Inc. | 4.49 | 448.54 k shares | 0.00 | Common equity | Long | USA |
ARADIGM CORP PIPE
|
1.48 | 148.01 k shares | 0.00 | Common equity | Long | USA |
CHINOOK THERAPEUTICS INC CVR RT
|
1.16 | 115.82 k shares | 0.00 | Common equity | Long | USA |
ALNAQ Allena Pharmaceuticals, Inc. | 0.94 | 93.68 k shares | 0.00 | Common equity | Long | USA |
AXLA Axcella Health Inc. | 0.66 | 66.45 k shares | 0.00 | Common equity | Long | USA |
CODIAK BIOSCIENCES INC WT 09/15/2027
|
0.46 | 46.00 k shares | 0.00 | Common equity | Long | USA |
ARADIGM CORP
|
0.12 | 11.95 k shares | 0.00 | Common equity | Long | USA |
MEDAVAIL HOLDINGS INC PIPE
|
0.01 | 55.00 shares | 0.00 | Common equity | Long | USA |